$XPOF

Xponential Fitness outlook hit by weaker sales, slower studio expansion

Xponential Fitness (NYSE:XPOF) cut its 2026 revenue and EBITDA guidance to $250M-$260M and $91M-$97M, respectively, due to weaker sales and slower studio expansion. UBS lowered its price target to $4.50 and reduced revenue and EBITDA forecasts. The company expects 150 net studio openings, down 25% annually, and merchandise revenue pressure. Shares fell 3% to $3.71.

Original reporting
Published Sep 16, 2026, 7:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 8:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Xponential Fitness outlook hit by weaker sales, slower studio expansion — source image
Decision brief

The 30-second read

$XPOFBearishHigh
01

Why it matters

Guidance cut reflects weaker same‑store sales and slower expansion, likely prompting short‑term sell‑offs.

02

Market read

The downgrade adds pressure to the fitness‑studio niche and may influence related consumer‑discretionary stocks.

03

What to watch

Potential cost efficiencies from the new logistics partner and younger‑member growth could offset slower studio openings.

Relevance 8/10Novelty 8/10Timing: post‑market today

Background

Xponential Fitness operates a portfolio of boutique fitness studios; recent earnings showed a 6% decline in Q1.

Company-level read

Ticker impact

$XPOFBearishHigh confidence
Context

UBS cut its price target and Xponential Fitness lowered FY2026 revenue to $250‑260M and EBITDA to $91‑97M.

Expected impact

Downside pressure of 5‑10% over the next week.

Evidence & confidence

Lowered guidance and reduced studio openings signal weaker growth; analysts have already trimmed targets.

Market effects

Fitness‑studio sector may see broader valuation pressure as expansion slows.

U.S. consumer discretionary stocks could face modest pullback.

Limited to U.S. market; no immediate global ripple.

Counterpoint

If the 8% market growth materializes, XPOF could rebound faster than peers.

Key entities

  • UBS

    Reduced price target to $4.50 and lowered revenue forecasts.

Related articles

$XPOFMed

Xponential Fitness Announces Rights Plan

Xponential Fitness (XPOF) adopted a stockholder rights plan, or 'poison pill,' to protect shareholder interests during its strategic review. The plan activates if a party acquires 19.9% or more of Class A shares and expires in October 2027. XPOF shares rose 4.1% to $5.16, with a market cap of $255 million.

$XPOFMed

Xponential Fitness adopts poison pill amid strategic review

Xponential Fitness (NYSE:XPOF) adopted a poison pill to prevent any investor from acquiring 19.9% or more of its Class A shares. The plan, effective immediately, allows other shareholders to buy discounted shares if the threshold is crossed. The board aims to encourage negotiation before acquisitions. The company is reviewing strategic alternatives with Jefferies as advisor. The plan expires on October 11, 2027, unless earlier terminated.

$XPOFMed

Why Xponential Fitness (XPOF) Stock Is Up Today

Xponential Fitness (XPOF) stock rose 5.5% after Club Pilates, part of its brand portfolio, announced over 1,500 global studios and launched Decades Week. Shares closed at $3.88, up 6.4%. The company has seen high volatility, with a 51.6% YTD decline and 56.9% drop from its 52-week high.

$XPOFLow

Xponential Fitness Names Jennifer Ryu as CFO

Xponential Fitness Inc. appointed Jennifer Ryu as CFO, effective Oct. 19. She succeeds John Meloun, who left in March. Ryu has 25 years of financial experience, including roles at Resources Connection Inc. and Deloitte. CEO Mike Nuzzo praised her public company experience and operational mindset.

$XPOFMed

Xponential Fitness (XPOF) Swings To A Loss And Cuts Guidance

Xponential Fitness (XPOF) reported Q2 revenue of $66M, down 13% YoY, and a net loss of $4.8M. The company cut full-year guidance, citing weaker same-store sales and higher costs. Despite challenges, XPOF opened 67 new studios and expects to open 150 net new studios for the year, with adjusted EBITDA guidance of $91M to $97M.

$XPOFMed

Why Xponential Fitness (XPOF) Stock Is Trading Up Today

Xponential Fitness (XPOF) shares rose 9.4% after Fund 1 Investments disclosed a 9.9% stake, citing undervaluation. The firm plans to discuss operational and strategic opportunities. XPOF closed at $5.68, up 8.3%. The company previously cut full-year guidance due to weak profitability and same-store sales declines.